Bill Ackman Can Run But he Can’t Escape Valeant Lawsuit

From Hedge Fund News From HedgeCo.Net
March 16, 2017 - 10:09am
(New York Post) Bill Ackman may have sold his stake in Valeant Pharmaceuticals but he can’t kick the habit as lawsuits continue. On Wednesday, California US District Judge David Carter permitted Allergan shareholders to pursue their case against Ackman’s Pershing […]


Continue reading this article »